Skip to main content
OpenTrials
Completed

NCT Number: NCT02575443

Neuromuscular Block and Anesthetic Depth Monitoring

The purpose of this study is to evaluated whether the depth of neuromuscular block may affect the unicon value of anesthetic depth monitoring system (ADMS).

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Gall bladder disease
  • American Society of Anesthesiologist physical status 1 or 2

Exclusion criteria

  • Pregnancy
  • Body mass index < 16
  • Body mass index >30
  • Neuromuscular disease
  • Previous intraabdominal surgery

Treatment and study plan

Rocuronium (MB group)

Drug

Count of train-of-four: 1-2 Titration of rocuronium dose

Rocuronium (DB group)

Drug

Post-tetanic count: 1-2 Titration of rocuronium dose

Primary outcomes

  1. Total infused dose of propofol

    Time frame: At 1 min after the anesthesia is finished

Secondary outcomes

  1. Electromyographic index presented on the anesthetic depth monitoring system

    Time frame: Through study completion, an average of 2 hours

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Important dates

Study start
2015
Primary completion
2017
Study completion
2017
First posted
Oct 14, 2015
Registry last updated
Oct 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.